Bioshares Etf Buy Hold or Sell Recommendation

BBP -  USA Etf  

USD 47.13  1.03  2.14%

Considering the 90-day investment horizon and your highly speculative risk level, our recommendation regarding Bioshares Biotech Products is 'Buy'. Macroaxis provides Bioshares Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBP positions. The advice algorithm takes into account all of Bioshares Biotech's available fundamental, technical, and predictive indicators you will find on this site.

Bioshares Advice 

The advice is provided from Bioshares Biotech's buy-and-hold perspective. Continue to Bioshares Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual funds such as Bioshares and provide practical buy, sell, or hold recommendation based on selected investing horizon and risk tolerance towards Bioshares Biotech Products.

Execute Bioshares Biotech Buy or Sell Advice

The Bioshares recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bioshares Biotech Products. Macroaxis does not own or have any residual interests in Bioshares Biotech Products or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bioshares Biotech's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Bioshares BiotechBuy Bioshares Biotech


Very steadyDetails

Hype Condition


Current Valuation

Fairly ValuedDetails

Odds of Distress

Very SmallDetails

Economic Sensitivity

Follows the market closelyDetails

Analyst Consensus

Not AvailableDetails
For the selected time horizon Bioshares Biotech Products has a Risk Adjusted Performance of (0.09), Jensen Alpha of (0.12), Total Risk Alpha of (0.05) and Treynor Ratio of (0.26)
Our investment recommendation tool can be used to complement Bioshares Biotech trade advice provided by experts. It analyzes the etf's potential to grow against your specific risk preferences and investment horizon. Please makes use of Bioshares Biotech one year return and equity positions weight to make buy, hold, or sell decision on Bioshares Biotech.

Bioshares Biotech Trading Alerts and Improvement Suggestions

Bioshares Biotech generated a negative expected return over the last 90 days
The fund holds 97.81% of its assets under management (AUM) in equities

Bioshares Biotech Returns Distribution Density

The distribution of Bioshares Biotech's historical returns is an attempt to chart the future uncertainty of Bioshares Biotech's future price movements. The chart of the probability distribution of Bioshares Biotech stock daily returns describes the distribution of returns around its average expected value. We use Bioshares Biotech Products price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bioshares Biotech returns is essential to provide solid investment advice for Bioshares Biotech stock.
Mean Return-0.15Value At Risk-2.14
Potential Upside1.63Standard Deviation1.21
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bioshares Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Bioshares Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Bioshares Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bioshares Biotech Products backward and forwards among themselves. Bioshares Biotech's institutional investor refers to the entity that pools money to purchase Bioshares Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Royal Bank Of CanadaFund Units77.9 KM
Note, although Bioshares Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bioshares Biotech Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bioshares Biotech or Virtus sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bioshares Biotech stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bioshares stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.60
Overall volatility
Information ratio -0.07

Bioshares Biotech Volatility Alert

Bioshares Biotech Products exhibits very low volatility with skewness of 0.03 and kurtosis of 0.17. However, we advise investors to further study Bioshares Biotech Products technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bioshares Biotech's etf risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bioshares Biotech's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Bioshares Biotech Implied Volatility

Bioshares Biotech's implied volatility exposes the market's sentiment of Bioshares Biotech Products stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bioshares Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bioshares Biotech stock will not fluctuate a lot when Bioshares Biotech's options are near their expiration.

Bioshares Biotech Fundamentals Vs Peers

Comparing Bioshares Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bioshares Biotech's direct or indirect competition across all of the common fundamentals between Bioshares Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bioshares Biotech or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Bioshares Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bioshares Biotech by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Bioshares Biotech to competition
FundamentalsBioshares BiotechPeer Average
Price to Earning18.03 X3.15 X
Price to Book1.66 X0.39 X
Price to Sales5.60 X0.33 X
One Year Return12.54 %(0.97) %
Three Year Return6.73 %3.23 %
Five Year Return10.37 %1.12 %
Net Asset26.68 M2.29 B
Equity Positions Weight97.81 %52.82 %

About Bioshares Biotech Buy or Sell Advice

When is the right time to buy or sell Bioshares Biotech Products? Buying financial instruments such as Bioshares Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Bioshares Biotech investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Bioshares Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation Theme
Companies involved in production and services of recreational goods, foods, and accessories. Recreation theme has 27 constituents.
View All  Next Launch Recreation
Continue to Bioshares Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Bioshares Biotech information on this page should be used as a complementary analysis to other Bioshares Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Bioshares Etf analysis

When running Bioshares Biotech price analysis, check to measure Bioshares Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioshares Biotech is operating at the current time. Most of Bioshares Biotech's value examination focuses on studying past and present price action to predict the probability of Bioshares Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioshares Biotech's price. Additionally, you may evaluate how the addition of Bioshares Biotech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
The market value of Bioshares Biotech is measured differently than its book value, which is the value of Bioshares that is recorded on the company's balance sheet. Investors also form their own opinion of Bioshares Biotech's value that differs from its market value or its book value, called intrinsic value, which is Bioshares Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioshares Biotech's market value can be influenced by many factors that don't directly affect Bioshares Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioshares Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioshares Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioshares Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.